Legal Representation
Attorney
Neal Wolgin
USPTO Deadlines
Next Deadline
115 days remaining
NOA E-Mailed - SOU Required
Due Date
May 11, 2026
Extension Available
Until November 11, 2026
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 11, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 16, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 16, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 10, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 19, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 19, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 19, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 19, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 19, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 12, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 12, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 12, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 2, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 2, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 2, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 23, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 22, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jun 22, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jun 18, 2025 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jan 14, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 14, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research, development, and testing of biopharmaceutical preparations for cell, gene, and stem cell therapies; Scientific services, namely, research, development, and testing in the field of processes for cell, gene, and stem cell therapies; Stem cell research services and clinical research in the field of gene therapy; Consulting services in the fields of biopharmaceutical research and development and genetic science
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SCIENTIFIC"